Frontlight ResearchEarly access
Trial site
Tennessee Oncology-Nashville/Sarah Cannon Research Institute
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer3 trials
- Childhood cancers2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 25 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed3 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Seagen Inc.4 trials
- American Society of Clinical Oncology1 trial
- Karyopharm Therapeutics Inc1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Terminated
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026